OpenNeedle Ask your own

Question explored with the scientific record

Metavive 1 as a thyroid support medicine

Oct 1, 2026 · 7 sources used · OpenNeedle synthesis
The evidence does not name Metavive 1, so there is no way to assess its ingredients, safety, or efficacy for thyroid support from these records.

The retrieved studies cover individual nutrients like iodine, selenium, zinc, and L-carnitine, and their effects on thyroid function in specific populations [1][3][4][5]. But none of them test a product called Metavive 1. Without knowing what is in it, no judgment is possible. If the product contains these nutrients, the evidence on each is mixed and context-dependent: selenium helped in some autoimmune thyroid conditions but not in others [6][7], iodine can both correct deficiency and cause dysfunction if overused [2][3], and L-carnitine acted as a peripheral thyroid hormone antagonist in one small trial [1]. None of this tells you whether Metavive 1 as a combination is safe or effective.

My call: there is no evidence on Metavive 1 in these records. Confidence: not clear — the question cannot be answered from what was retrieved.

Keep digging

Sources used 7

  1. Effects of L-carnitine on Thyroid Hormone Metabolism and on Physical Exercise Tolerance Hormone and Metabolic Research (2005) Thin

    A comprehensive review summarizing evidence that L-carnitine can modestly enhance exercise tolerance by increasing muscle carnitine and fatty acid oxidation, while also acting as a peripheral antagonist of thyroid hormone action, with clinical data suggesting potential benefits …

    DOI: 10.1055/s-2005-870424
  2. Iodine Intake and Maternal Thyroid Function During Pregnancy Epidemiology (2010) Thin

    This study investigates the association between maternal iodine intake and thyroid function during early pregnancy in three regions of Spain, revealing that high iodine supplement intake may lead to maternal thyroid dysfunction even in iodine-sufficient populations.

    DOI: 10.1097/EDE.0b013e3181c1592b
  3. Iodine Supplementation Decreases Hypercholesterolemia in Iodine-Deficient, Overweight Women: A Randomized Controlled Trial , The Journal of Nutrition (2015) Thin

    This randomized controlled trial demonstrates that iodine supplementation significantly reduces serum TSH levels and improves lipid profiles, particularly total cholesterol, in overweight, iodine-deficient Moroccan women.

    DOI: 10.3945/jn.115.213439
  4. Effects of Zinc and Selenium Supplementation on Thyroid Function in Overweight and Obese Hypothyroid Female Patients: A Randomized Double-Blind Controlled Trial Journal of the American College of Nutrition (2015) Thin

    This randomized double-blind controlled trial investigates the effects of zinc and selenium supplementation on thyroid function in overweight and obese female hypothyroid patients, revealing significant improvements in serum FT3 and FT4 levels with zinc supplementation alone or …

    DOI: 10.1080/07315724.2014.926161
  5. The Influence of Selenium Supplementation on Postpartum Thyroid Status in Pregnant Women with Thyroid Peroxidase Autoantibodies The Journal of Clinical Endocrinology & Metabolism (2007) Thin

    This study investigates the effects of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies, finding that supplementation significantly reduces the incidence of postpartum thyroid dysfunction and hypothyroidism.

    DOI: 10.1210/jc.2006-1821
  6. Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease Frontiers in Endocrinology (2021) narrative review Mixed

    A narrative review concludes that selenium has uncertain effectiveness in Graves' hyperthyroidism, with null RCTs and a positive trial in selenium-deficient patients, but is beneficial in mild Graves' orbitopathy based on a randomized trial.

    DOI: 10.3389/fendo.2020.608428
  7. Effects of selenium in patients with autoimmune thyroiditis Clinical and experimental thyroidology (2019) primary study Strong

    In an open randomized 12-month trial in women with elevated TPO-Ab, selenium 200 µg/day did not change thyroid function or autoimmunity in euthyroid carriers, but increased achievement of euthyroidism by month 12 in the small subclinical hypothyroidism subgroup.

    DOI: 10.14341/ket10299

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →